Skip to main content
. 2018 Aug 22;2:35. doi: 10.1186/s41687-018-0063-4

Table 4.

Saturation grid

Sex F M M M M M M M F M M M M M M M M
Age, years 54 62 73 57 66 68 77 84 60 76 65 82 76 64 69 64 72
Treatment-related side effects; n (%)
 Nausea; 6 (35.3%) x o o o o o
 Diarrhea; 2 (11.8%) x o
 Swelling in legs; 2 (11.8%) x o
 Skin breaks/cracks; 1 (5.9%) x
 Constipation; 3 (17.6%) x o o
 Vomiting; 2 (11.8%) x o
 Fatigue/lack of energy/tiredness; 10 (58.8%) x o o o o o o o o o
 Pain/soreness in/around liver; 3 (17.6%) x o o
 Pain/tenderness at insertion/injection site; 5 (29.4%) x o o o o
 Blisters on feet; 1 (5.9%) x
 Soreness around incision; 1 (5.9%) x
 Flu-like feeling; 1 (5.9%) x
 Lack/loss of appetite/interest in food; 6 (35.3%) x o o o o o
 Hair loss; 4 (23.5%) x o o o
 Weakness; 1 (5.9%) x
 Increased sweating; 1 (5.9%) x
 Uncontrollable urination; 1 (5.9%) x
 Urinary urgency; 1 (5.9%) x
 Uncontrollable defecation; 1 (5.9%) x
 Slept a lot after procedure; 1 (5.9%) x
 Itching; 1 (5.9%) x
 Memory issues; 2 (11.8%) x o
 Weight loss; 1 (5.9%) x
 Longer to stop bleeding; 2 (11.8%) x o
 Pain on inside/outside of legs; 1 (5.9%) x
 Pain under ribs near right kidney; 1 (5.9%) x
 Chills; 1 (5.9%) x
 Clogged left ear; 1 (5.9%) x
 Nosebleeds; 1 (5.9%) x
 Headaches; 2 (11.8%) x o
 Distended abdomen that causes pain; 1 (5.9%) x
 Gas (feeling like needing to burp); 1 (5.9%) x
 Unpleasant taste in mouth; 1 (5.9%) x

Participants are listed sequentially, from left to right, in the order in which interviews were completed

x, first mention by patient; o, subsequent mention by patient